STOCK TITAN

December 2020 Stock Losers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data through the session. 22 of 22 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of December 2020 Every stock ranked by its December 2020 gain, with or without news

100

Ranked drops

-78.08%

Largest, APRE

94.9%

Events still below the pre-news close, day +5

5.4%

Median growth of the drop, day +5

Filter and sort
Rows

100 ranked drops in December 2020

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 APRE under $25M today -78.08% against the close of 12/24/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS)

08:00 ET premarket

2 OVID -55.86% against the close of 12/01/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of Angelman Syndrome Did Not Meet Primary Endpoint

16:52 ET after hours

3 ARCT More than one ranked move this month 2+ ranked moves -54.17% against the close of 12/28/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Arcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data

16:01 ET after hours

4 AMRH release reads positive -54.05% against the close of 12/28/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Release reads positive, stock fell 54.05% AMERI Holdings' Stockholders Approve All Proposals To Complete Tender Offer For Jay Pharma Shares

10:10 ET intraday

5 CYTH -53.33% against the close of 12/08/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering

12:52 ET intraday

6 SLS More than one ranked move this month 2+ ranked moves -52.60% against the close of 12/10/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast

08:30 ET premarket

7 SNGX under $25M today -49.27% against the close of 12/21/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients

06:30 ET premarket

8 ARPO -46.67% against the close of 12/11/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Aerpio Announces Statistically Significant Topline Results from Razuprotafib Glaucoma Phase 2 Trial

17:00 ET after hours

9 ATOS under $25M today -39.03% against the close of 12/08/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Atossa Therapeutics Announces Pricing of $20.0 Million Underwritten Public Offering

21:45 ET after hours

10 SINO -37.40% against the close of 12/08/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Sino-Global Shipping America Announces Pricing of Approximately $4.8 million Registered Direct Offering Priced At-The-Market

09:00 ET premarket

11 SCPH -35.64% against the close of 12/04/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory scPharmaceuticals Inc. Receives Complete Response Letter from FDA for FUROSCIX®

08:00 ET premarket

12 MKGI -33.33% against the close of 12/28/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Monaker Group Announces Bought Deal Offering

17:14 ET after hours

13 EARS Also on the opposite board this month on both boards -33.08% against the close of 12/01/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Auris Medical Holding Ltd. Prices $8,000,000 Common Shares Offering Priced At-the-Market

08:45 ET premarket

14 ACY Also on the opposite board this month on both boards -33.07% against the close of 12/28/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Listing / Compliance AeroCentury Corp. Listing Standards Compliance Update

17:00 ET after hours

15 OCGN Also on the opposite board this month on both boards -32.31% against the close of 12/23/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Ocugen Establishes Vaccine Scientific Advisory Board

19:15 ET after hours

16 CTK -31.44% against the close of 12/14/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CooTek Announces Third Quarter 2020 Unaudited Results

00:02 ET premarket

17 SLRX -31.34% against the close of 12/10/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Salarius Announces Exercise Of Warrants For $3.5 Million Of Gross Proceeds To Be Used For Ongoing Development Of Seclidemstat

11:32 ET intraday

18 TRIT -31.14% against the close of 12/16/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Triterras Schedules Business Update Call for Tuesday, January 5, 2021 at 10 a.m. ET

09:22 ET premarket

19 GLBS -29.05% against the close of 12/04/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Globus Maritime Limited Reports Financial Results for the Quarter and Nine-Month Period Ended September 30, 2020

16:05 ET after hours

20 CLEU -28.91% against the close of 12/14/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings China Liberal Education Holdings Limited Reports Sales Results of its Self-developed Textbooks Published by Fudan University Press

07:30 ET premarket

21 NBRV -28.24% against the close of 12/10/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Nabriva Therapeutics Announces Proposed Public Offering

16:01 ET after hours

22 HSTO More than one ranked move this month 2+ ranked moves -27.12% against the close of 12/30/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Histogen Announces Pricing of $14.0 Million Upsized Public Offering

22:25 ET after hours

23 CLRB under $25M today -25.99% against the close of 12/22/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Cellectar Biosciences Announces Proposed Underwritten Public Offering and Concurrent Private Placement

17:27 ET after hours

24 EXPR -25.95% against the close of 12/02/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Express, Inc. Reports Third Quarter 2020 Results

06:45 ET premarket

25 STAF -25.84% against the close of 12/23/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Staffing 360 Solutions Announces Proposed Public Offering of Common Stock

16:30 ET after hours

26 NERV -25.71% against the close of 11/30/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Minerva Neurosciences Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of Roluperidone

08:00 ET premarket

27 VERO -25.59% against the close of 12/21/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Venus Concept Inc. Announces Proposed Public Offering

16:05 ET after hours

28 ATNM -24.63% against the close of 12/28/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Actinium Announces Successful Pre-Planned Ad Hoc Interim Analysis of Phase 3 SIERRA trial

08:30 ET premarket

29 SESN -24.14% against the close of 12/18/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Sesen Bio Submits Completed Biologics License Application to the FDA for Vicineum™ and Has Requested Priority Review

08:00 ET premarket

30 TOUR -24.11% against the close of 11/30/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Tuniu Announces Unaudited Third Quarter 2020 Financial Results

05:32 ET premarket

31 ONCT Also on the opposite board this month on both boards -23.33% against the close of 12/09/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Oncternal Therapeutics Announces $40.0 Million Bought Deal Offering

18:07 ET after hours

32 SPLK -23.25% against the close of 12/02/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Splunk Inc. Announces Fiscal Third Quarter 2021 Financial Results

16:02 ET after hours

33 BLCT -22.84% against the close of 12/01/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings BlueCity Announces Third Quarter 2020 Unaudited Financial Results

04:57 ET premarket

34 AYTU under $25M today -22.76% against the close of 12/10/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Aytu BioScience Announces $10.0 Million Bought Deal Offering

17:35 ET after hours

35 MIRM -22.75% against the close of 12/14/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Mirum Pharmaceuticals Announces Pricing of Public Offering of Common Stock

21:00 ET after hours

36 VTVT -22.56% against the close of 12/15/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results vTv Therapeutics Announces Topline Results of Phase 2 Elevage Study of Azeliragon in Patients with Mild Alzheimer’s Disease and Type 2 Diabetes

18:15 ET after hours

37 GLSI Also on the opposite board this month on both boards -22.46% against the close of 12/10/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Greenwich LifeSciences Announces Poster Presentation on Its GP2 Phase III Clinical Trial Design for Recurring Breast Cancer

06:00 ET premarket

38 LPCN under $25M today -21.43% against the close of 12/08/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Lipocine Announces Deletion of Unauthorized Changes to Company's Website

20:40 ET after hours

39 BOSC -21.25% against the close of 12/29/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution BOS Better Online Solutions Ltd. Announces $2 Million Registered Direct Offering

08:30 ET premarket

40 SOL More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -21.17% against the close of 12/01/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings ReneSola Power Announces Third Quarter 2020 Financial Results

16:05 ET after hours

41 HGEN Also on the opposite board this month on both boards -21.14% against the close of 12/24/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Humanigen Secures U.S. Patent for Lenzilumab in Preventing Cytokine Storm and Neurotoxicity Related to CAR-T Cell Therapy

07:00 ET premarket

42 JRJC -21.02% against the close of 12/29/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings China Finance Online Reports Third Quarter and First Nine Months of 2020 Unaudited Financial Results

17:00 ET after hours

43 BLRX under $25M today -20.99% against the close of 12/15/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results BioLineRx Announces Final Results from Phase 2a COMBAT/KEYNOTE-202 Triple Combination Study of Motixafortide in Second Line Metastatic Pancreatic Cancer (PDAC)

06:01 ET premarket

44 UXIN -20.71% against the close of 12/16/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Uxin Reports Unaudited Second Quarter of Fiscal Year 2021 Financial Results

01:27 ET premarket

45 AMPY -20.67% against the close of 12/10/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Amplify Energy Announces Secondary Public Offering of Common Stock for Selling Stockholders

16:30 ET after hours

46 CTRM under $25M today Also on the opposite board this month on both boards -20.53% against the close of 12/30/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Castor Maritime Inc. Announces Pricing of $18.0 Million Registered Direct Offering

09:00 ET premarket

47 TALO -20.27% against the close of 12/08/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Talos Energy Announces Public Offering Of Common Stock

16:05 ET after hours

48 ENG -20.19% against the close of 11/30/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Former Dynamic Industries President Roger Westerlind Named As President Of ENGlobal U.S., Inc.

08:30 ET premarket

49 IRTC -20.13% against the close of 12/01/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement iRhythm Technologies Comments on Centers for Medicare and Medicaid Services 2021 Medicare Physician Fee Schedule Final Rule

03:53 ET premarket

50 SLS More than one ranked move this month 2+ ranked moves -20.07% against the close of 12/11/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution SELLAS Announces Pricing of $16.2 Million Registered Direct Offering

20:10 ET after hours

51 OSMT -20.04% against the close of 12/29/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Osmotica Pharmaceuticals plc Receives Complete Response Letter from U.S. Food and Drug Administration for Arbaclofen Extended Release Tablets

17:15 ET after hours

52 FCEL -20.00% against the close of 12/01/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution FuelCell Energy Announces Launch of Offering of Common Stock

16:46 ET after hours

53 CRHM -19.71% against the close of 12/22/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement CRH Medical Corporation Announces Customer Update

21:43 ET after hours

54 CRTX -19.62% against the close of 12/03/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Cortexyme’s Phase 2/3 GAIN Trial of Atuzaginstat (COR388) in Patients with Alzheimer’s Disease Successfully Advances Past Interim Analysis

07:00 ET premarket

55 GME -19.36% against the close of 12/08/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings GameStop Reports Third Quarter Results, A Positive Start to Fourth Quarter with November Comparable Store Sales Increasing 16.5% And Sustained Progress Toward Long-Term Strategic Objectives

16:06 ET after hours

56 AQB under $25M today -19.26% against the close of 12/09/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock

16:01 ET after hours

57 MDGS -19.21% against the close of 12/01/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Medigus Prices $13 Million Underwritten Public Offering of ADSs

21:12 ET after hours

58 SOL More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -19.17% against the close of 12/22/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition ReneSola Power Announces Sale of 15.4 MW of Solar Assets in Romania

06:00 ET premarket

59 INFI -19.13% against the close of 12/08/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Infinity Pharmaceuticals Presents Front-Line Triple Negative Breast Cancer Data from Ongoing Phase 2 MARIO-3 Trial at the 2020 San Antonio Breast Cancer Symposium

09:10 ET premarket

60 SCYX -19.10% against the close of 12/16/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution SCYNEXIS Announces Launch of $50 Million Public Offering of Common Stock and Warrants

16:21 ET after hours

61 ARCT More than one ranked move this month 2+ ranked moves -19.07% against the close of 12/07/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Arcturus Therapeutics Announces Proposed Public Offering of Common Stock

16:33 ET after hours

62 FREQ -19.04% against the close of 12/17/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Frequency Therapeutics to Host Investor Event on the Potential for Restorative Treatments for Acquired Sensorineural Hearing Loss

08:00 ET premarket

63 AMPE -18.88% against the close of 12/28/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Ampio Receives feedback from the FDA on Ampio's Proposed Modifications to the special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee

09:15 ET premarket

64 IQ -18.85% against the close of 12/15/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution iQIYI Announces Proposed Offering of Convertible Senior Notes and Proposed Offering of American Depositary Shares

17:15 ET after hours

65 YEXT -18.84% against the close of 12/03/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Yext, Inc. Announces Third Quarter Fiscal 2021 Results

16:15 ET after hours

66 DTIL -18.82% against the close of 12/03/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL)

06:30 ET premarket

67 TRCH -18.68% against the close of 12/11/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell Metamaterial and Torchlight Sign Definitive Agreement for Business Combination

07:00 ET premarket

68 IPHA -18.66% against the close of 12/10/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement  Innate Pharma to return US and EU Lumoxiti commercialization rights to AstraZeneca

01:00 ET premarket

69 FTFT under $25M today -18.50% against the close of 12/23/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Future Fintech Group Inc. Announces $8 Million Registered Direct Offering

08:41 ET premarket

70 LITB -18.21% against the close of 12/04/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings LightInTheBox Reports Third Quarter 2020 Financial Results

06:00 ET premarket

71 SUMO -18.10% against the close of 12/04/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Sumo Logic Expands Board of Directors with Addition of Industry Go-To-Market Veteran Tracey Newell

09:00 ET premarket

72 METX -18.09% against the close of 12/07/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Meten EdtechX Announces Temporary Offer Allowing Warrants to be Exercised at a Reduced Price

16:30 ET after hours

73 TCDA -17.73% against the close of 12/08/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Tricida Announces Updates on Veverimer Development Program, Regulatory Status and New Patent Extending Protection through 2038

16:05 ET after hours

74 HSTO More than one ranked move this month 2+ ranked moves -17.61% against the close of 11/30/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Histogen Announces Preliminary Week 18 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men

08:00 ET premarket

75 LE -17.48% against the close of 12/02/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Lands' End Announces Third Quarter Fiscal 2020 Results

06:45 ET premarket

76 SPCE -17.38% against the close of 12/11/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Virgin Galactic Update on Test Flight Program

06:59 ET premarket

77 APDN -17.31% against the close of 12/17/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Applied DNA Reports 2020 Year End and Fiscal Fourth Quarter Financial Results

16:05 ET after hours

78 CONN -17.24% against the close of 12/07/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Conn’s, Inc. Reports Third Quarter Fiscal Year 2021 Financial Results

06:00 ET premarket

79 NNA -17.21% against the close of 11/30/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Navios Maritime Acquisition Corporation Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2020

08:08 ET premarket

80 CLNN -16.73% against the close of 12/30/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update

17:38 ET after hours

81 ZYNE -16.51% against the close of 12/16/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome

06:30 ET premarket

82 SPCB -16.41% against the close of 12/29/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Listing / Compliance SuperCom Regains Compliance with Nasdaq Minimum Bid Price Requirement

12:27 ET intraday

83 TTGT -16.39% against the close of 12/11/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution TechTarget Announces Proposed Offering of Convertible Senior Notes

07:30 ET premarket

84 QURE -16.19% against the close of 12/18/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program

07:05 ET premarket

85 CMBM -16.15% against the close of 12/03/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Cambium Networks Corporation Announces Pricing of Secondary Offering

20:14 ET after hours

86 MRAM -16.05% against the close of 12/15/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Everspin Announces Leadership Changes

17:17 ET after hours

87 AGIO Also on the opposite board this month on both boards -16.01% against the close of 12/07/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease

16:30 ET after hours

88 PURE under $25M today -15.91% against the close of 12/15/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings PURE Bioscience Reports Fiscal First Quarter 2021 Financial Results

16:05 ET after hours

89 PLAB -15.90% against the close of 12/08/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Photronics Reports Full Year and Fourth Quarter Fiscal 2020 Results

06:00 ET premarket

90 BB -15.86% against the close of 12/17/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings BlackBerry Reports Sequential Software and Services Revenue Growth, Non-GAAP Profitability and Positive Free Cash Flow for Fiscal 2021 Third Quarter

17:05 ET after hours

91 NFE -15.74% against the close of 12/15/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution New Fortress Energy Announces Offering of Class A Common Stock

16:46 ET after hours

92 DADA -15.65% against the close of 12/02/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Dada Announces Pricing of Follow-On Public Offering of American Depositary Shares

03:40 ET premarket

93 SRG -15.34% against the close of 12/10/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Seritage Growth Properties Announces CEO Transition

16:15 ET after hours

94 BRPA Also on the opposite board this month on both boards -15.08% against the close of 12/29/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results NeuroRx and Relief Conclude Enrollment in their Phase 2b/3 Trial of RLF-100™ for Critical COVID-19 with Respiratory Failure

01:00 ET premarket

95 ZM -15.06% against the close of 11/30/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Zoom Reports Results for Third Quarter Fiscal Year 2021

16:05 ET after hours

96 CMTL -14.97% against the close of 12/09/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Comtech Telecommunications Corp. Announces Results for Its Fiscal 2021 First Quarter and Updates Its Financial Targets for Fiscal 2021

16:07 ET after hours

97 BNTX -14.95% against the close of 12/11/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results catalyst from a later release the same session Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19

23:15 ET after hours

98 DLTH -14.93% against the close of 12/02/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Duluth Holdings Inc. Announces Third Quarter Fiscal 2020 Financial Results

08:30 ET premarket

99 TMBR -14.88% against the close of 12/14/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Lead Asset TMB-001

08:00 ET premarket

100 CLWT under $25M today -14.81% against the close of 12/29/2020 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Euro Tech Holdings Company Limited Reports Interim Results For The Six Months Ended June 30, 2020

06:00 ET premarket

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 61 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

7 candidate events for this board could not be anchored to a trading session and are not listed.

1 event was left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In December 2020, the median decliner’s drop was 5.4% larger five sessions later; the largest catalyst group was Offering / Dilution, 30 of the 100 events, at a median of -21.0%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still below the pre-news close at day +5
Offering / Dilution 30 30.0% -21.0% -21.3% 96.7% of 30
Earnings 22 22.0% -19.1% -23.1% 95.5% of 22
Clinical Trial Results 19 19.0% -21.0% -27.6% 100.0% of 19
Other Announcement 12 12.0% -19.2% -18.8% 83.3% of 12
M&A / Acquisition 5 5.0% Fewer than 10 events in this group, so no figures are shown.

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

4 other catalyst types, 12 events: FDA & Regulatory, Leadership Change, Listing / Compliance, Reverse Merger / Shell.

How much of the drop held

Horizon Still below the pre-news close (close-to-close basis) Median change since the measured close as a share of the drop
Day +1 100.0% of 100 2.9% larger drop, of 100
Day +5 94.9% of 99 5.4% larger drop, of 99
Month end 92.7% of 96 7.1% larger drop, of 96
Month end falls before day +5 for 16 of these 96 events, so this row is not a later horizon than the one above it. 96 of the 100 events have a month-end close later than the measured session; 3 have it on the measured session itself, and 1 has no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside December 2020

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsLargest drop
ARCT 2Clinical Trial Results, Offering / Dilution -54.17%
SLS 2Clinical Trial Results, Offering / Dilution -52.60%
HSTO 2Offering / Dilution, Other Announcement -27.12%
SOL 2Earnings, M&A / Acquisition -21.17%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsLargest drop
TLGT 2020-11, 2020-10, 2020-09 -33.01%
LQDA 2020-11, 2020-10 -27.71%
ADXS 2020-11, 2020-10 -27.27%
NKLA 2020-11, 2020-09 -26.92%
KNDI 2020-11, 2020-09 -22.69%
BIOC 2020-11, 2020-09 -22.40%
TTNP 2020-11, 2020-09 -22.31%
MRIN 2020-11, 2020-10 -43.62%
AMRS 2020-11, 2020-09 -25.80%
BSGM 2020-10, 2020-09 -39.64%
CRBP 2020-10, 2020-09 -75.89%
ISR 2020-10, 2020-09 -29.57%
MGEN 2020-10, 2020-09 -23.49%
HYMC 2020-10, 2020-09 -16.15%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market48.0%
  • Intraday4.0%
  • After hours48.0%

Volume against normal

  • Under 5x21 events, 21.0%
  • 5x to 20x51 events, 51.0%
  • Over 20x28 events, 28.0%

Industry

  • Pharmaceutical preparations23 events, 23.0%
  • Biological products (excluding diagnostic substances)3 events, 3.0%
  • Crude petroleum & natural gas2 events, 2.0%
  • Electric & other services combined2 events, 2.0%
  • Radio & TV broadcasting & communications equipment2 events, 2.0%
  • Semiconductors & related devices2 events, 2.0%

17 other industries, 18 events

Industry not known: 48.0%

1 event on this board carries the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against November 2020

100 events from November 2020 in the comparable window.

November 2020 median -22.4%, selected from the 8,496 events in that month's eligible pool.

December 2020 median -20.1%, 2.3 points shallower than November 2020. December 2020's median is taken over the 100 ranked rows, selected from the 6,258 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.